The cancer profiling market is projected to register a CAGR of 10.8% during the forecast period.
The market for cancer profiling is fragmented, with several major players operating in the market. The factors owing to the competition include the rising launch of innovative cancer profiling products and rising investments in cancer genomics by companies, among others. Some companies currently operating in the market are Illumina, Inc., QIAGEN, Sysmex Corporation, NeoGenomics Laboratories, and HTG Molecular Diagnostics, Inc., among others.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook